Related Experiment Video

Updated: May 24, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Paediatric anticoagulation guidelines

Elise Schapkaitz1, Gayle Gillian Sherman, Barry Frank Jacobson

  • 1National Health Laboratory Services, and Department of Haematology, , University of the Witwatersrand, Johannesburg, South Africa. elise.schapkaitz@nhls.ac.za

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|March 3, 2012
PubMed

Insights

This study provides practical guidelines for managing venous thrombo-embolism (VTE) in children and neonates. The recommendations aim to improve laboratory investigations and anticoagulation therapy in pediatric patients.

Area of Science:

  • Pediatric Hematology
  • Thrombosis and Hemostasis

Background:

  • Understanding of venous thrombo-embolism (VTE) in pediatric populations is advancing.
  • Clear indications for laboratory investigations and therapeutic interventions in pediatric VTE are lacking.

Purpose of the Study:

  • To develop evidence-based guidelines for the clinical management of VTE in children and neonates.
  • To standardize laboratory investigations and therapeutic interventions for pediatric VTE.

Main Methods:

  • A comprehensive review of available literature and existing evidence-based guidelines for pediatric antithrombotic therapy.
  • Development of draft guidelines through consensus agreement among experts.
  • Adjudication of guidelines by independent international experts to ensure objectivity.

Main Results:

  • Concise and practical guidelines for the clinical management of VTE in pediatric patients.
  • Recommendations for laboratory investigation of VTE in neonates and children.
  • Guidelines reflect current best practices in the field.

Conclusions:

  • The developed guidelines aim to enhance the clinical management of VTE in children and neonates.
  • Implementation of these recommendations is expected to improve anticoagulation practices in this age group.
  • These guidelines provide a framework for consistent and effective VTE care in pediatric patients.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...